ISSN 1516-9332 printed version
ISSN 1809-4562 online version

INSTRUCTIONS TO AUTHORS

 

 

The Brazilian Journal of Pharmaceutical Sciences/Revista Brasileira de Ciências Farmacêuticas (RBCF) accepts for publication Original Papers applicable to the fields of Pharmaceutical Sciences; Reviews and Current Comment Articles, which are published under the Editorial Board invitation to recognized experts or when they are spontaneously submitted by the authors in the form of abstracts to have their importance evaluated. A critical vision of the subject with insertions of results of previous works in the field in relation to the state of the art in the country must be included; Short Communications reporting new methods and previews of works on researches of outstanding importance in which originality justify a quick publication. A maximum of 2000 words excluding tables, figures and references is an acceptable limit. One table, one figure and ten references may be added, and Book Reviews of the latest editions, prepared by specialists invited by the Editorial Board. Thematic Supplements as well as those related to scientific meetings can be published under the Editorial Board agreement.

Manuscripts can be submitted by either Brazilian or foreign specialists written in one of the following languages: Portuguese, English or Spanish. A manuscript is accepted with the understanding that the material has not been previously published, except in abstract form, and that it is not simultaneously under consideration by any other journal. All manuscripts submitted to Brazilian Journal of Pharmaceutical Sciences / Revista Brasileira de Ciências Farmacêuticas that follow the instructions to authors are subject to peer review by two or more independent, anonymous referees chosen by the Scientific Editor. Additional opinions are sought by the Scientific Editor when there are substantial differences between reviewers. After being reviewed all manuscripts are forwarded to the Editorial Board for a final decision. Rejected manuscripts may be resubmitted for consideration without any reference to the previous submission as a new manuscript after being properly and significantly restructured. If revision is necessary, the authors are asked to resubmit the dated, revised manuscript incorporating the suggestions and recommendations of the referees within two months. Revisions not received within two months from the date of notice will have its process canceled. All revisions must be accompanied with a letter detailing the changes made to the original document; changes should also be indicated directly on the manuscript. Revisions may be re-reviewed at the discretion of the Scientific Editor. Papers accepted for publication will have their copyright assigned to the REVISTA. A copyright transfer form will be sent to the authors for signature together with the final proof of the paper.

 

Scope and policy

The Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences edited trimestrally by the School of Pharmaceutical Sciences - University of São Paulo, giving priority to the publication of Original Articles of Pharmaceutical Sciences. It also publishes short communications, Technical Notes and Book Reviews. By request of the Editorial Board Review Articles will be accepted for publication. Also these articles can be previously submitted in abstract form to evaluate the interest in publishing them. The provision of up-to-date information on the latest advanced areas of Pharmaceutical Sciences is one of the main services that RBCFUSP offers to its readers. Contributions written by foreign specialists are also accepted.

 

Manuscripts' form and presentation

STRUCTURE

Title Page: This should include the manuscript full title (it must be brief providing exact information of the contents), authors' full names, institutional affiliations (University, College, Department). Give as a foot-note the name, full address including E-mail of the corresponding author identified with an asterisk.

Summary: On a separate page, provide a summary of not more than 200 words. It must be structured and consist of four parts. Each part of the structured summary should concisely and specifically describe the objectives of the study, techniques used, the essential results and what the authors concluded from the results.

Uniterms: These should be strictly related to the contents and limited to 6 (six).

Introduction: This should state briefly and clearly the objectives of the investigation with reference to previous works. Extensive review of the literature should be avoided and substitute for references of recent publications where such reviews may be found.

Material and Methods: These should be described in sufficient detail that the work can be reproduced. Procedures and techniques readily available in the literature require only a citation of the original source, except when they are substantially modified. Reports of experimental studies on humans and animals must certify that the research received prior approval by the appropriate institutional review body (Committee of Bioethics).

Results and Discussion: Results must be presented concisely and in logical order. Where possible use figures or tables to present data rather than text. When appropriate give the range, standard deviation and indicate the significances of differences between numerical values obtained. Discussion should interpret the results and assess their significance in relation to previous work in the field. Speculation not warranted by actual data should be avoided. Presenting those items separately is optional.

Conclusions: These must be drawn from the text and restricted to the limits of data obtained

Abstract in Portuguese: It should be preceded by the title in Portuguese. This should follow the same content of the summary presented in English. Members of the Editorial Board can kindly assist those authors not fluent in the Portuguese language.

Uniterms in Portuguese: must follow uniterms in English.

Acknowledgments: These should be typed in a special paragraph under separate heading preceding the section of References. They should be kept to a minimum consistent with the requirements of courtesy and disclosure.

References: They should be prepared and listed according to The Brazilian Association of Technical Standards (ABNT.NBR 6023). Entries should be arranged in alphabetical order by author at the end of the paper. All authors' names should be given. "Accuracy of reference data is the responsibility of the author". For research and examples see the site www.bcq.usp.br.

PRESENTATION OF MANUSCRIPTS

Manuscripts should be sent in three copies, in an official/regular sheet of paper (30-36 lines, double spaced) in the Word for Windows program or preferentially on line via http://www.rbcf.br. All submissions must be accompanied with a letter signed by the authors. RBCF requires that the accepted final corrected copy of each manuscript be submitted electronically (on micro floppy disk or via http://www.rbcf.br). Traditional paper version is also accepted.

 

Sending of manuscripts

Impressed manuscripts should be sent to the address bellow:

Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences
Divisão de Biblioteca e Documentação do Conjunto das Químicas/USP
Av. Prof. Lineu Prestes, 950
Caixa Postal 66083
05315-970 - São Paulo - SP - Brasil
Contato telefônico: Fone: (011) 3091.3804 FAX: (011) 3097.8627
E-mail: rbcf@usp.br

 

[Home] [About this journal] [Editorial board] [Subscription]


© 2009 Revista Brasileira de Ciências Farmacêuticas

Av. Prof. Lineu Prestes, n.950 - Cidade Universitária - Caixa Postal 66083
05315-970 São Paulo SP Brasil
Tel.: +55 11 3091.3804
Fax: +55 11 3097.8627


bjps@usp.br